- Home
- ATAI vs OSUR Comparison
ATAI vs OSUR Comparison
Compare ATAI & OSUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATAI
- OSUR
- Stock Information
- Founded
- ATAI 2018
- OSUR 2000
- Country
- ATAI Germany
- OSUR United States
- Employees
- ATAI N/A
- OSUR N/A
- Industry
- ATAI Biotechnology: Pharmaceutical Preparations
- OSUR Medical/Dental Instruments
- Sector
- ATAI Health Care
- OSUR Health Care
- Exchange
- ATAI Nasdaq
- OSUR Nasdaq
- Market Cap
- ATAI 271.6M
- OSUR 266.7M
- IPO Year
- ATAI 2021
- OSUR 1986
- Fundamental
- Price
- ATAI $1.45
- OSUR $3.44
- Analyst Decision
- ATAI Strong Buy
- OSUR Hold
- Analyst Count
- ATAI 4
- OSUR 2
- Target Price
- ATAI $9.00
- OSUR $5.50
- AVG Volume (30 Days)
- ATAI 2.1M
- OSUR 1.0M
- Earning Date
- ATAI 03-17-2025
- OSUR 05-07-2025
- Dividend Yield
- ATAI N/A
- OSUR N/A
- EPS Growth
- ATAI N/A
- OSUR N/A
- EPS
- ATAI N/A
- OSUR N/A
- Revenue
- ATAI $308,000.00
- OSUR $185,827,000.00
- Revenue This Year
- ATAI N/A
- OSUR N/A
- Revenue Next Year
- ATAI $20.00
- OSUR $8.41
- P/E Ratio
- ATAI N/A
- OSUR N/A
- Revenue Growth
- ATAI N/A
- OSUR N/A
- 52 Week Low
- ATAI $0.78
- OSUR $2.69
- 52 Week High
- ATAI $2.85
- OSUR $6.69
- Technical
- Relative Strength Index (RSI)
- ATAI 43.24
- OSUR 45.82
- Support Level
- ATAI $1.33
- OSUR $3.40
- Resistance Level
- ATAI $1.48
- OSUR $3.55
- Average True Range (ATR)
- ATAI 0.11
- OSUR 0.15
- MACD
- ATAI -0.01
- OSUR 0.02
- Stochastic Oscillator
- ATAI 43.41
- OSUR 56.52
About ATAI ATAI Life Sciences N.V.
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.
About OSUR OraSure Technologies Inc.
OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.